User Testing of the Palliate Intervention, Supporting Lay Carers to Prepare and Administer Anticipatory Medications to Loved Ones at Home at the End of Life.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- End of Life
- Sponsor
- Imperial College London
- Enrollment
- 21
- Locations
- 1
- Primary Endpoint
- Acceptability
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
The aim of this study is to evaluate the acceptability, safety and efficiency of the Palliate intervention.
The Palliate intervention is a nurse-led process that includes training and documentation materials to support lay carers in administering top up medications to loved ones at the end of life at home. The Palliate intervention was designed based on the CARiAD* intervention using user testing and has been successfully piloted and rolled out in Central and North West London National Health Service (NHS) Foundation Trust.
*CARer-ADministration of as-needed sub-cutaneous medication for breakthrough symptoms in homebased dying patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Individuals aged 18 years or older and able to communicate in English.
Exclusion Criteria
- •Individuals aged less than 18 years old and/or unable to communicate in English.
Outcomes
Primary Outcomes
Acceptability
Time Frame: Through study completion per participant (≤ 5 weeks)
Participant scores of acceptability of the intervention as per the responses on the Theoretical Framework of Acceptability (TFA) questionnaire. Free text or verbal responses noted when completing the questionnaire will be thematically analysed as informed by the TFA. The TFA questionnaire is an eight-item questionnaire. Raw total scores range from 8 (the worst possible score) to 40 (the best possible score).
Secondary Outcomes
- Efficiency(Through study completion per participant (≤ 5 weeks))
- Actual and perceived barriers and opportunities from the participants regarding the use of the Palliate intervention(Through study completion per participant (≤ 5 weeks))
- Learnability/ Retained learning(Through study completion per participant (≤ 5 weeks))
- Usability(Through study completion per participant (≤ 5 weeks))
- Factors contributing to error, potential errors and acceptability of the intervention(Through study completion per participant (≤ 5 weeks))
- Incidence of error(Through study completion per participant (≤ 5 weeks))